1. Shukla, A. A., Hubbard, B., Tressel, T., Guhan, S. & Low, D. Downstream processing of monoclonal antibodies—application of platform approaches. J. Chromatogr. B 848, 28–39 (2007).
2. Kelley, B. Very large scale monoclonal antibody purification: the case for conventional unit operations. Biotechnol. Prog. 23, 995–1008 (2007).
3. Points to Consider in the Manufacture and Testing of Monoclonal Antibody Products for Human Use, CBER, FDA, February 28, (1997).
4. European Commission, The Rules Governing Medicinal Products in the EU, vol. III, addendum 3, Guidelines on the Quality, Safety and Efficacy of Medicinal Products for Human Use, Production and Quality Control of Medicinal Products Derived by rDNA Technology, III/3477/92, p. 47.
5. Jiang, C., Liu, J., Rubacha, M. & Shukla, A. A. A mechanistic study of Protein A chromatography resin lifetime. J. Chromatogr. A 1216, 5849–5855 (2009).